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Objective: We present the results obtained in 40 patients with chronic atrial
fibrillation using direct intraoperative radiofrequency to perform atrial fibrillation
surgery.
Methods: Between April 1995 and June 2002, 40 patients underwent surgery for
atrial fibrillation using radiofrequency ablation and cardiac surgery at the Depart-
ment of Cardiovascular Surgery of the University of Bologna. There were 8 men and
32 women with a mean age of 62  11.6 years (range: 20 to 80 years).
Results: Concomitant surgical procedures were: mitral valve replacement (n  13),
mitral valve replacement plus tricuspid valvuloplasty (n 11), combined mitral and
aortic valve replacement (n 8), and combined mitral and aortic valve replacement
plus tricuspid valvuloplasty (n  5). Moreover, 1 patient underwent tricuspid
valvuloplasty plus atrial septal defect repair, another required aortic valve replace-
ment plus coronary artery bypass graft, and a third underwent aortic valve replace-
ment. After the mean follow-up time of 16.5  2.5 months survival was 92.8% and
the overall cumulative rate of sinus rhythm was 88.5%.
Conclusions: We conclude that the radiofrequency ablation procedure is a safe and
effective means of curing atrial fibrillation with negligible technical and time
requirements, allowing recovery of the sinus rhythm and atrial function in the great
majority of patients with atrial fibrillation who underwent cardiac surgery (88.5% of
our study population).
Atrial fibrillation (AF) is a common arrhythmia present in 0.4% ofthe general population and in more than 1% of the population over60 years of age. About 40% to 60% of patients undergoing mitralvalve surgery have AF, thus compromising the clinical outcome.The detrimental sequelae of AF are irregular heartbeat, compro-mised hemodynamics due to the absence of a synchronous atrio-
ventricular contraction, and the risk of systemic thromboembolic events.
Restoration of the sinus rhythm (SR) with atrioventricular resynchronization may
be difficult in patients with lone or chronic AF. The procedure consists of the
surgical approach described by James Cox, namely making linear lesions in the right
and left atria to prevent the occurrence of multiple reentering circuits. This surgical
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procedure is extensive and time-consuming and requires
great surgical skill. More recently, Haissaguerre and col-
leagues1 have demonstrated that radiofrequency (RF) abla-
tion is able to confine the origin of paroxysmal AF to the
rapidly firing foci in the pulmonary veins. The efficacy of
RF ablation in patients with chronic AF undergoing cardiac
surgery has been evaluated and the clinical outcome is
presented here.
Methods
Operative Technique
Between April 1995 and June 2002, 40 patients with chronic AF
underwent cardiac surgery and surgery to treat AF at the Depart-
ment of Cardiovascular Surgery of the University of Bologna. The
preoperative characteristics of the patients are shown in Table 1.
All patients underwent cardiopulmonary bypass with bicaval and
aortic cannulation under moderate hypothermia (32°C); myocar-
dial protection was assured by antegrade crystalloid cardioplegia.
The lesions were made by a Cobra Flex catheter (Boston Scientific,
San Jose, Calif) at a temperature of 70°C to 80°C for a period of
2 minutes in the left atrium and 90 seconds in the right atrium.
After a standard lateral left atriotomy, the probe was placed on the
left atrial endocardium 5 to 10 mm medially from the right pul-
monary vein orifices. The ablation probe was then used to create a
circumferential lesion around the left pulmonary veins, at least 5
mm from their orifices. Connecting lesions were created from the
left atrial appendage to the ablation line around the left pulmonary
veins and from this lesion to the anteromedial commissure of the
mitral valve. A final lesion connecting the 2 lesions encircling the
pulmonary vein was created. The left atrial appendage was then
excised and the stump of the left atrial appendage was closed with
running polypropylene suture. We also performed the ablation in
the right atrium to prevent the early postoperative onset of atrial
flutter: a single lesion was created along the crista terminalis from
the superior vena cava to the inferior vena cava. A connecting
lesion was then created from the lower end of this lesion onto the
atrioventricular groove, low down and opposite the orifice of the
coronary sinus, to create a block in the cavotricuspid isthmus area
(Figure 1). Two patients underwent aortic valve replacement and
the probe was applied on the epicardium of the dome of the left
atrium, connecting the pulmonary veins, which had previously
been isolated.
Antiarrhythmic prophylactic treatment was carried out on a
routine basis. Amiodarone was the drug of choice. Its administra-
tion was begun after induction of anesthesia: 300 mg intravenous
bolus, followed by 1200 mg/24 hours intravenously until the end
of the first postoperative day; beginning with the second postop-
erative day, oral administration of 200 mg/24 hours was begun.
After discharge, a maintenance regimen of 200 mg/24 hours was
continued. The pharmacological treatment was discontinued 6
months after the operation.
Follow-up
The mean follow-up time was 15.5 months (range: 2-74 months).
Clinical history and 12-lead electrocardiogram (ECG) were taken
during each follow-up visit. Sinus rhythm was defined as a su-
praventricular rhythm with P waves on the standard 12-lead ECG.
Six months after surgery, echocardiography was performed, in-
cluding transmitral and transtricuspid Doppler echocardiography.
E and A waves were detected to evaluate the atrial contraction. At
least 1 Holter monitoring of rhythm was performed in each patient
6 months after hospital discharge.
Statistical Analysis
Continuous variables are expressed as the mean  SD. Student t
test for paired data was used to assess the statistical significance of
differences between pre- and postoperative parameters. A P value
.05 was considered significant. The following preoperative vari-
ables were considered for any possible relationship with surgical
results: AF duration, age, and left atrial diameters. Survival was
calculated according to the Kaplan-Meier method.
Results
As a consequence of the ablation there were no local or
general complications, namely atrial wounds. Concomitant
surgical procedures were: mitral valve replacement (n 
13), mitral valve replacement plus tricuspid valvuloplasty (n
 11), combined mitral and aortic valve replacement (n 
8), and combined mitral and aortic valve replacement plus
tricuspid valvuloplasty (n  5). Moreover, 1 patient under-
went tricuspid valvuloplasty plus atrial septal defect repair
and 2 patients required aortic valve replacement, 1 of whom
also required coronary artery bypass graft. The mean car-
diopulmonary bypass time was 126.3  33.4 minutes and
the crossclamp time was 104.8  31.5 minutes. The mean
intensive care unit stay was 2.4 days. The cumulative in-
hospital mortality was 7.5%: 1 patient died of sepsis, 1 of
severe hepatic cirrhosis (of 20 years), and 1 of left ventric-
ular disruption. Three patients (7%) needed permanent
TABLE 1. Preoperative characteristics and surgical proce-
dures
Variable n  40 P value
Age (years) 62 11.6 NS
Sex (male) 8 NS
Sex (female) 32 NS
LA dimension (mm) 56.05 7.6 NS
AF duration (months) 61.9 NS
Ejection fraction (%) 56.8 13.3 NS
NYHA class 2.8 0.5 NS
MVR 13
MVR  TVP 11
MVR  AVR 8
MVR  AVR  TVP 5
TVP  ASD and VSD repair —
TVP  ASD repair 1
AVR 1
AVR  CABG 1
Redo 6 (15%) NS
AF, Atrial fibrillation; ASD, atrial septal defect; AVR, aortic valve replace-
ment; CABG, coronary artery bypass graft; LA, left atrial; MVR, mitral valve
replacement; NYHA, New York Heart Association; TVP, tricuspid valve-
plasty; VSD, ventricular septal defect.
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pacemakers implanted because of postoperative bradycar-
dia. No patient had transitory neurologic symptoms after the
surgical procedure. The cumulative rates of SR at discharge
was 85%.
Follow-up
All 40 patients completed at least 6 months of follow-up.
The duration of the follow-up ranged from 7 to 22 months
(mean 16.5  2.5). Cumulative survival was 92.8%. At the
12-lead ECG, the cumulative rate of SR was 88.5%. Biatrial
contraction was documented during transthoracic Doppler
echocardiography in 76.5% of the patients. Twenty-nine
patients (72.5%) were under treatment with warfarin so-
dium and 9 patients (22.5%) were undergoing antiarrhyth-
mic therapy (sotalol or amiodarone). We noted a significant
improvement of the New York Heart Association (NYHA)
functional class after surgery: 20 patients (50%) were in
NYHA class I and 20 (50%) in NYHA class II.
Discussion
In 1991, Cox and colleagues2-6 described a new procedure
for the radical surgical treatment of atrial fibrillation: the
maze procedure. Initially it was performed as an isolated
cardiac procedure. However, as experience with this tech-
nique has grown, it has been performed concomitantly with
other cardiac procedures.7,8 It has been noted that the cor-
rection of the underlying cardiac pathology alone usually
fails to abolish AF.9 Kosakai and colleagues10 have shown
the advantage of the maze procedure for atrial fibrillation in
patients undergoing simultaneous cardiac surgery. The neg-
ative effects of AF are widely known, particularly in com-
bination with valve diseases. Therefore, a specific surgical
intervention is needed to eliminate AF. Excellent results
have been described for the surgical treatment of chronic
AF associated with organic heart disease at the expense,
however, of extensive atrial incisions and suturing and
greater blood loss, as well as longer cardiac arrest.11,12
In an attempt to reduce the procedure time and to sim-
plify the surgical technique, modifications of the original
maze procedure have been developed,13 including the ap-
plication of RF energy.14 Heat propagation is based on
resistive and passive mechanisms. In the immediate prox-
imity of the probe, tissue is heated to 50°C to 60°C with
consequent coagulation and irreversible destruction of cell
and collagen structures. Further away from the probe, the
resistance offered by tissue decreases exponentially and the
heart rate rapidly decreases. Thus, ablation of the peripheral
portion of the lesion results from passive heating with the
same effect of irreversible damage being reached over a
longer period of time. Both resistive and passive heating
propagate in all of the directions so that the tissue lesion is
similar in depth and width. Once transmurality is achieved,
the effects of RF lesions are the same as those of the other
major techniques with effective ablation of atrial muscle, an
antiarrhythmic effect, and no significant proarrhythmic ac-
tivity from the scar tissue.15
The treatment of AF by the application of RF ablation in
the atria is based on the concept of preventing functional
macro-reentrant circuits16 or eliminating anatomically de-
termined circuits.17 All the lesions are made in the endo-
cardium and replace most of the surgical incisions of the
Figure 1. The surgical scheme of the RF ablation in the left and right atrium.
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previous techniques. The RF ablation procedure requires 15
to 20 minutes of elective cardiac arrest time in contrast to at
least 50 to 60 minutes of the Cox maze III procedure.16,18
The importance of interrupting conduction along the coro-
nary sinus to avoid the development of postsurgical atrial
flutter has been recognized.19 Therefore, we also performed
RF ablation in the isthmus, between the tricuspid valve
annulus and the inferior vena cava. In our study, patients
had a long duration of AF (61.9 months) and large left atrial
dimensions (56.05  6 mm) but we did not find any
statistically significant relationship between these preoper-
ative data and the surgical results. Restoration of SR was
demonstrated in 88.5% of patients at follow-up.
These data are comparable to the results documented by
different groups,20-25 who found restoration of SR between
70% and 98%, depending on patient preoperative charac-
teristics (lone AF, concomitant heart diseases) and the sur-
gical techniques. All our patients had chronic AF; 12.5% of
the patients underwent combined mitral and aortic valve
replacement plus tricuspid valvuloplasty and 15% (6 pa-
tients) of the previous patients were reoperations. Therefore,
we believe that RF ablation should also be considered a safe
and effective procedure in eliminating AF in patients suf-
fering from a multiple valve disease and in those undergo-
ing a reoperation.
An important aim of restoring SR is to produce the
contraction of both atria, restoring an adequate electrome-
chanical synchrony and decreasing the risk of thromboem-
bolism. In our study, biatrial contraction was restored in
76.5% of the patients. Our data are equivalent to the data of
other groups, reporting the occurrence of biatrial contrac-
tion in 66.7% to 99% of patients depending on the baseline
characteristics.26 RF ablation usually prolongs the cross-
clamp time only of 10 to 15 minutes. This is a significant
advantage in older patients with poor ventricular function
and/or multiple valve disease, making it possible to enlarge
the indications to restore sinus rhythm surgically.
In conclusion, we believe that the use of RF energy is
safe and effective and simplifies the Cox maze III procedure
in patients undergoing cardiac surgery, by restoring SR and
atrial contraction in the majority of patients and also by
reducing operating time.
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